Internal Medicine · Eastman, GA
NPI
1487636742
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
911 Plaza Ave, Suite C
Eastman, GA, 31023
Phone (478) 374-5774
Groups this clinician bills Medicare through
Medicare paid, 2024
$585K
10,502 services
Medicare patients, 2024
1,628
Average age 72
Drug cost, 2024
$8.3M
121,047 prescriptions
Company payments, 2025
$1,935
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael T Peacock was code 99308 (snf e&m), 5,438 times for 1,209 patients. In total Michael T Peacock billed 10,502 services in 47 codes, and Medicare paid $585K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 5,438 | 1,209 | $50.82 | $276K |
| 99309 SNF E&M | Facility | 1,764 | 867 | $77.10 | $136K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 965 | 116 | $44.37 | $43K |
| 99307 SNF E&M | Facility | 812 | 568 | $22.31 | $18K |
| 99306 SNF E&M | Facility | 190 | 190 | $130.18 | $25K |
| 99457 E&M - Miscellaneous | Office | 189 | 23 | $33.99 | $6,425 |
| 99214 Office E&M - Established | Office | 184 | 84 | $68.58 | $13K |
| 99454 E&M - Miscellaneous | Office | 165 | 22 | $30.71 | $5,067 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 157 | 157 | $120.98 | $19K |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Facility | 134 | 134 | $154.43 | $21K |
| 99213 Office E&M - Established | Office | 110 | 46 | $59.32 | $6,525 |
| 99305 SNF E&M | Facility | 105 | 104 | $98.38 | $10K |
| 99458 E&M - Miscellaneous | Office | 62 | 19 | $25.46 | $1,578 |
| 83036 Blood Count | Office | 27 | 21 | $9.32 | $252 |
| 96372 Injection Administration | Office | 26 | 18 | $7.52 | $195 |
By year: 2022 $356K for 8,653 services; 2023 $354K for 8,094 services; 2024 $585K for 10,502 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 27 | 21 | $9.32 | $252 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael T Peacock prescribed most often to Medicare patients was Atorvastatin Calcium, with 4,786 prescriptions and refills. In total Michael T Peacock wrote 121,047 Medicare prescriptions that cost $8.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 4,786 | 4,897 | 598 | $60K |
| Amlodipine Besylate Generic | 3,764 | 3,858 | 427 | $33K |
| Gabapentin Generic | 3,687 | 3,760 | 421 | $55K |
| Levothyroxine Sodium Generic | 3,049 | 3,134 | 297 | $34K |
| Furosemide Generic | 3,007 | 3,075 | 359 | $21K |
| Eliquis Apixaban | 2,814 | 2,823 | 253 | $705K |
| Potassium Chloride Generic | 2,771 | 2,864 | 341 | $60K |
| Trazodone Hcl Generic | 2,612 | 2,630 | 324 | $36K |
| Pantoprazole Sodium Generic | 2,438 | 2,497 | 330 | $38K |
| Mirtazapine Generic | 2,303 | 2,309 | 302 | $53K |
| Divalproex Sodium Generic | 2,291 | 2,291 | 288 | $90K |
| Famotidine Generic | 2,025 | 2,052 | 180 | $18K |
| Losartan Potassium Generic | 1,990 | 2,123 | 241 | $23K |
| Clopidogrel Clopidogrel Bisulfate | 1,939 | 1,997 | 210 | $22K |
| Quetiapine Fumarate Generic | 1,917 | 1,925 | 229 | $49K |
Brand drugs: 18,359 claims; generic drugs: 102,358 claims; opioid claims: 3,234.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael T Peacock $1,935 ($1,935 in general payments such as food, travel and fees) from 17 companies. The largest payer was Neurocrine BioSciences, Inc. with $692.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 19 | $692 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 15 | $489 |
| SK Life Science, Inc. | 2 | $157 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $104 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $103 |
| Lundbeck LLC | 5 | $93.37 |
| UCB, Inc. UCB.BR | 3 | $70.44 |
| Esperion Therapeutics, Inc. ESPR | 2 | $29.5 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $27.62 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $24.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.